Novavax (NVAX) Total Debt Growth (1y) (2011 - 2015)
Novavax (NVAX) Total Debt Growth (1y) (2011 - 2015) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 103.99% |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.84% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Novavax | 788.01 Mn | -2.33 Mn | 108.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | -70.73% |
| Dec 31, 2014 | -60.66% |
| Mar 31, 2014 | -33.26% |
| Dec 31, 2013 | 33.33% |
| Sep 30, 2013 | 108.45% |
| Jun 30, 2013 | 313.25% |
| Mar 31, 2013 | 222.50% |
| Dec 31, 2012 | 151.00% |
| Sep 30, 2012 | 164.33% |
| Jun 30, 2012 | 33.33% |
| Dec 31, 2011 | -6.25% |